Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition
Article in American Journal of Hematology (June 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in American Journal of Hematology (June 2024)
Article in Blood Reviews (November 2023)
Article in International Journal of Environmental Research and Public Health (January 2023)